Evidence-Based Recommendations for Induction Treatment of Newly Diagnosed Transplant-Eligible Multiple Myeloma Patients; A Scoping Review
Olga Lytvynova(Cleveland Clinic), Faiz Anwer(Cleveland Clinic), Ali Shahbaz Baloch(Weiss Memorial Hospital), Vasanthan Muthusamy Kumarasamy(University at Buffalo, State University of New York), Abdul Rafae(University of Arkansas for Medical Sciences), Rohan Prasad(Michigan State University), Debduti Mukhopadhyay(University at Buffalo, State University of New York), Jenna Jwayyed(Indiana University – Purdue University Indianapolis), Ahmed Salman(Unity Health System), Maha Hameed(Sarasota Memorial Hospital)
Cited by 2
Related Papers
Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results
|Nature Medicine|2023|239
Pulmonary Artery Denervation as a New Therapeutic Option for Pulmonary Hypertension: A Systematic Review and Meta-Analysis
|Current Problems in Cardiology|2023|11
Transcatheter Vacuum-Assisted Mass Extraction Versus Surgical Debridement for Vegetations in Tricuspid Valve Infective Endocarditis: A Meta-Analysis of Observational Studies
|The American Journal of Cardiology|2023|7